Stockreport

Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance

Clover Health Investments, Corp. - Class A Common stock  (CLOV) 
PDF Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an incre [Read more]